Addressing Anaemia in Cancer Patients: Education and Innovations

This presentation examines anaemia in cancer patients, focusing on its prevalence, causes, and prognostic impact. It explores how newer cancer therapies, radiotherapy, and innovative treatments affect anaemia. Key considerations include the management of anaemia, with emphasis on blood transfusions, ESAs, and iron supplementation, alongside emerging therapies like hepcidin inhibitors. Quality of Life (QoL) aspects are discussed, highlighting anaemia's daily impact using assessment tools like...